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Background: Recent studies have showed that FEV1/FVC describing correspondence between the forced
expiratory volume in one second (FEV1) and forced vital capacity (FVC) depends significantly on age. However, the
nature of this dependence is uncertain. The study aim is to analyze mathematically the relationship between FEV1
and FVC to find a cause of the FEV1/FVC dependence on age in healthy subjects.
Methods: The relationship was examined for 1,120 males and 1,625 females – Polish (Caucasian) population,
healthy, never-smoking, aged 18 – 85 years, who performed a technically adequate spirometry maneuver. Lung
functions were measured using the LungTest1000 (MES, Poland) with maximal effort according to the ATS/ERS
guidelines.
Results: A very strong, age-independent linear relationship between FEV1 and FVC was found in healthy individuals
(the correlation coefficient r = 0.96). It can be described with the equation FEV1 =A x FVC +C, where A = 0.84 and
C= −0.23 (−0.36) for females (males). As C is different from zero, FEV1/FVC depends on FVC because FEV1/
FVC =A+ C/FVC, in average. And thus, since FVC is significantly age-dependent, FEV1/FVC has to be also
age-dependent because of the term C/FVC. In particular, the smaller the FVC value because of advanced age, the
more significant the fall of FEV1/FVC.
Conclusions: FEV1/FVC dependence on age in healthy individuals is of mathematical rather than biological nature.
Due to the strong correlation between FEV1 and FVC in healthy subjects, the difference between patient’s FEV1 and
the FEV1 value expected for patient’s FVC seems to be a more natural, age-independent description of the
correspondence between patient’s FEV1 and FVC.
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SpirometryBackground
Spirometry is the fundamental diagnostic method in ob-
structive lung diseases because it is easy and inexpensive
to perform, and thus it can be used as a screening test.
If the expiration is forced, the values of spirometric indi-
ces are almost independent of patient’s activity; they de-
pend only on the properties of the respiratory system
because of the airflow limitation phenomenon [1-3].
Evaluation of forced spirometry results begins with ana-
lysis whether bronchial airflow capacity quantified by
means of the forced expiratory volume in one second* Correspondence: tgol@ibib.waw.pl
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distribution, and reproduction in any medium(FEV1) corresponds to the lungs size estimated with the
forced vital capacity (FVC) or is too small. According to
the present recommendations, the relationship between
FEV1 and FVC is quantified by means of the ratio of
these indices, i.e. FEV1/FVC, introduced by Tiffaneau
and Pinnelli [4] about 60 years ago. If the value of FEV1/
FVC is smaller than its lower limit of normal (LLN), a
bronchial obstruction should be diagnosed.
In previous GOLD recommendations [5], irrespec-
tively of the age of examined subjects, the constant value
of FEV1/FVC equal to 70% was assumed as the LLN to
diagnose the obstruction in chronic obstructive pulmonary
disease, despite that existence of some dependence of
FEV1/FVC on age had been known. However, more recent
studies have shown that FEV1/FVC decreases with age sotral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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has to be taken into account [9].
Many authors have analyzed how FEV1/FVC
changes with age and which regression equation is
the best among others [6-8,10-14]. Accurate matching
of the equation is essential since an incorrect equa-
tion may lead to either the abandonment of a sick in-
dividual or the diagnosis of a non-existing disease
and unnecessary treatment of healthy individuals. Un-
fortunately, the present equations proposed by various
authors differ significantly in predictions, especially
for more advanced age, i.e. for such age range for
which incidence of obstructive lung diseases rises.
Moreover, the constant value equal to 70% versus
age-dependent LLN is still discussed [15].
Because of such meaning of FEV1/FVC, the prob-
lem “why it depends on age” should be also studied.
This paper contains a mathematical study because the
value of FEV1/FVC is not any directly measured
quantity; it is a mathematical index calculated from
two quantities that are measured. Therefore, the
following doubt might appear: is it possible that the
age-dependence of this index is an accidental effect of
its calculation method not matched to the nature of
the true relationship between FEV1 and FVC? To test
this hypothesis, a direct statistical analysis of the rela-
tionship in healthy individuals was performed.
The nature - whether mathematical or physiological
- of troublesome dependence of an index that is cal-
culated (not measured) on some factors may be very
important: if the nature is mathematical then another,
better mathematical index could be proposed, which
is the additional aim of this work.Table 1 Reference sample selection criteria and characteristic
Participants:
Total
Less age outside the range
Less ever smoking










Data are presented as the number of participants (n) or mean ± SD. FEV1- forced exMaterial and methods
Material
5130 females and 4716 males were examined within the
project “Hope for Lungs” which was conducted in
2002–2005 by the Military Institute of Medicine, War-
saw, Poland. With the permission of the Local Ethics
Committee, the authors utilized the database of that
project in the analysis of the relationship between FEV1
and FVC that is presented in this paper. It should be
noted that the same database was utilized in our other
works related to different matters: prediction equations
of a novel form [7] and an index for quantitative as-
sessment of correctness of the flow-volume curve [16].
That project involved spirometry screening for obstruct-
ive lung diseases in Poland. With a mobile laboratory,
the examinations were performed at 93 sites: both large
cities and small towns as well as villages throughout
Poland. For all subjects, after interview and written
consent from participants, the examination was per-
formed in sitting position using the same, regularly cali-
brated spirometer (LungTEST1000 by MES, Poland), in
summer (between May and September), from 9 am to
4 pm. All examinations were performed and analyzed
by the same group of six qualified employees perform-
ing routinely spirometry in the Central Clinical Hospital
of the Polish Ministry of National Defense.
Like during elaboration of prediction equations, only
data for healthy subjects were taken into account. There-
fore, the following subjects were excluded from the ana-
lysis (exclusion criteria): persons younger than 18 year
and older than 85 year, smokers, those reporting the oc-
currence of a chronic cough or dyspnea within the last












55 ± 16 57 ± 14
173 ± 7 161± 6
3.4 ± 1.0 2.4 ± 0.7
4.5 ± 1.2 3.1 ± 0.8
piratory volume in one second; FVC- forced vital capacity.
Table 2 Linear regression of FEV1 on FVC and on FVC
and age
FEV1 on FVC FEV1 on FVC and age
females females
FEV1= 0.84FVC – 0.23 FEV1= 0.77FVC+ 0.28 – 0.0052age
R2 = 92.0%, r = 0.96 R2 = 92.7%
males males
FEV1= 0.84FVC – 0.36 FEV1= 0.77FVC+ 0.32 – 0.0069age
R2 = 93.1%, r = 0.96 R2 = 93.6 %
FEV1 (liter)- forced expiratory volume in one second; FVC (liter) - forced vital
capacity; r- the correlation coefficient, R2 – fraction of explained variance. For
all values shown in the Table p < 0.0001.
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tions were used in the technical evaluation). The final
selection was performed by the authors taking into ac-
count both medical and technical criteria. 3505 females
and 3596 males were rejected due to failure to meet
these criteria. Consequently, the results for 1625 females
and 1120 males were used in the analysis. Table 1 pre-
sents details concerning these groups.
Data analysis
The strength of the relationship between FEV1 and FVC
was described quantitatively with the fraction of explained
variance (R2) and the correlation coefficient (r). As the
correlation coefficient appeared very high, the relationship
could be described accurately with a linear equation.
Therefore, the linear regression of FEV1 on FVC was
done. Age was used as an additional independent variable
of the regression to examine a possible increase in R2 sug-
gesting age influence on the relationship between FEV1
and FVC. Calculations were performed with the computer
system Statistica (StatSoft, USA).
Results
A very high correlation was evidenced between FEV1
and FVC, demonstrating thus a strong linear relation-
ship (r = 0.96 both for males and females) (Figure 1). The
assumed equation form for the linear regression of FEV1
on FVC was as follows:
FEV1 ¼ A FVCþ C ð1Þ
The values of the coefficients A and C for males and
females are shown in Table 2. The R2 coefficient is equal
to 93% for males and 92% for females, which means that
only 7–8% of the FEV1 variance cannot be explained
with the FVC variability. R2 increased very little when
age was added as the second independent variable in theFigure 1 Forced expiratory volume in one second (FEV1) versus force
studied material; thin lines – the linear regression; bold points creating cur
calculated separately in three ranges of age (blue- 18–40, black- 41–65, andregression of FEV1 (Table 2), which means that the rela-
tion between FEV1 and FVC is practically age-independ-
ent. Although age and height significantly influence both
FEV1 and FVC, they have a very insignificant influence
on the relationship between them (Figure 1). For ex-
ample, if an average healthy woman has FVC= 3.5 L, she
has FEV1 approximately equal to 2.75 L, whether she is
young and short (the left end of the blue line in Figure 1)
or of middle age and height (the middle of the black line
in Figure 1) or is tall but older (the right end of the red
line). Thus, the main result of the work could be
expressed as follows: in healthy subjects FEV1 depends
on FVC without respect to the other factors, including
age and height.
If FVC for an individual is known, the expected value
of FEV1 can be estimated with the formula 1 using the
coefficients from the Table 2. If this individual is healthy,
such an expected value of FEV1 should be approximately
equal to his/her real FEV1 since the correlation between
FEV1 and FVC is so high. If, however, a patient is
suffering from an obstructive lung disease, the difference
between the measured and expected values of FEV1 should
be significant.d vital capacity (FVC) in females and males. Light gray dots – the
ves – the moving 50th percentile of FEV1 for particular values of FVC
red- 66–85 years).
Figure 2 A graphical interpretation of FEV1/FVC decline with
age in healthy subjects. FEV1 and FVC for an individual can be
represented by one point on the plane determined by the
coordinate system: FVC and FEV1. The ratio FEV1 to FVC is equal to
the tangent of the angle α contained between the horizontal axis
(FVC-axis) and the vector leading out to that point from the
coordinate system origin. Thus, the lower value of the angle, the
smaller the FEV1/FVC value.
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the formula 1, also his/her FEV1/FVC might be approxi-
mated:
FEV1=FVC ¼ Aþ C=FVC ð2Þ
The formula 2 consists of the constant term A and the
term C/FVC, which is inversely proportional to FVC.
Thus, since FVC depends significantly on age, also
FEV1/FVC should depend on age, despite that the rela-
tion between FEV1 and FVC is age-independent. Figure 2
shows graphical interpretation of the above.
Discussion
Since both FEV1 and FVC depend on a common factor
that is age [7,8,11-14], one may expect some statistical
correlation between FEV1 and FVC. Moreover, assuming
that dependence of FEV1 and FVC on age in middle-aged
and elderly healthy subjects is linear [7,11], also the rela-
tionship between FEV1 and FVC should be linear. Direct
analysis of this relationship confirmed the linearity (for-
mula 1), however the correlation between FEV1 and FVC
appeared to be surprisingly high. In particular, regression
of FEV1 on FVC produced R2 being much higher than R2
obtained during regression of FEV1 or FVC on age for the
same sample of the Polish population [7].
The relationship between FEV1 and FVC can be
described precisely by means of a linear equation withthe constant term C different from zero. Such a value of
the term C is a result of small differences in the relative
rates of FEV1 and FVC decline with age. It can be
proved that if the dependence of FEV1 and FVC on age
is linear within some age range then:
C ¼ − SFEV1−SFVCð Þ  FEV10=SFVC ð3Þ
where: FEV10 is the mean value of FEV1 for the left end
of this age range, SFEV1 and SFVC are the decline rates of
FEV1 and FVC, respectively (SFEV1 = 1.070%/year and
SFVC =0.992%/year in Polish females, SFEV1 = 1.098%/year
and SFVC =0.968%/year in males [7]).
Neither original data used by other authors [8,11-14]
could be utilized to verify the existence of the constant
term being different from zero nor their equations could
be used in the formula 3 because those equations had
forms being physiologically uninterpretable. However
such a value of C appeared when values of FEV1 and FVC
predicted by those equations were used (Figure 3). Note
that all the curves in Figure 3 suggest the x-intercept dif-
ferent from zero, despite that some of these curves are not
appropriate for the population analyzed here. Comparison
of the relationship between values predicted with old
ECSC equations [11] (thin continuous lines in Figure 3)
with the relationships between FEV1 and FVC for subjects
in this study as well as predicted with more recent equa-
tions (the other lines in Figure 3) suggests movement of
the relationship to the right in comparison with ECSC (a
possible reason: less restrictive criterion for the forced ex-
piration time in the past causing underestimation of FVC
[7,8,18]).
If the constant term C was equal to zero, FEV1 would
be approximately proportional to FVC, i.e. FEV1=A×FVC.
Then, neglecting inter-individual differences, the FEV1/
FVC index being the quotient of FEV1 and FVC would
have the constant value equal to the proportionality con-
stant A, approximately equal to the FEV1/FVC predicted
value for the average young subject. However, because the
C value is different from zero, an additional term, which is
equal to C/FVC, appears in the expression defining the
average value of FEV1/FVC (formula 2). Since C is negative
(Table 2), this term is subtracted from A, which makes
FEV1/FVC lower than it would be without this additional
term. It should be noted that Burrows et al. [19] observed
some FEV1/FVC dependence on FVC in 1983.
As age influences significantly FVC, it also influences
FEV1/FVC because of the C/FVC term, and thus age-
dependence of FEV1/FVC is mainly an effect of the
method of calculation, not a symptom of some direct,
physiological influence of age on the relationship between
FEV1 and FVC. Certainly, a physiological influence
probably also exists but it is relatively small (Figure 1,
Table 2). Among others, it can be related to differences in
Figure 3 Predicted forced expiratory volume in one second (FEV1) versus forced vital capacity (FVC) for females. Light gray dots – the
studied material. Bold curves – the mean values of FEV1 and FVC predicted for females aged 20 to 80 year (height = 160, 165, and 170 cm) with
equations of various authors: ECSC [11], Lubinski and Golczewski [7], Brandli et al. [12], Langhammer et al. [13], Hankinson et al. [14], Falaschetti
et al. [8]. The red parts of the curves correspond to data for females younger than 35 years (they are partly covered by the black parts).
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a nonlinearity in the relationship for youngest subjects in
Figure 3.
Summarizing, FEV1/FVC, being a quantitative descrip-
tion of the relationship between FEV1 and FVC, depends
on age in the middle-aged and elderly healthy subjects des-
pite that this relationship per se is independent of age in
those subjects. It means that FEV1/FVC is not a good index
for quantifying the relationship because it suggests not
existing dependence.
According to the current recommendations, FEV1/FVC
is of key significance in the initial diagnosis of obstructive
diseases. Its value decides whether the examined individual
should be treated as suffering from obstructive lung disease
or not. Therefore, the value of its LLN predicted for a pa-
tient has to be determined accurately. Comparison
of regression equations proposed by different authors
(e.g. [6-8,10-14]) shows that the mean values and LLN of
FEV1/FVC in the Caucasian elderly significantly depend onthe author; e.g. the mean value varies between 70% and
80%. Hence it appears that FEV1/FVC improperly describes
the relationship between FEV1 and FVC as well as its really
accurate values are difficult to determine.
As has been shown, FEV1 is strongly connected with
FVC without respect to such factors important in spir-
ometry as age and height. Therefore, from the clinical
point of view, it would be convenient to simply assume
that in healthy persons FVC determines FEV1 without
respect to various factors. The authors realize that
FEV1/FVC is a very established spirometric index. Since,
however, it is a neither mathematically correct nor very
reliable index, the authors would like to propose a new
index to assess whether patient’s FEV1 corresponds to
his/her FVC like in healthy subjects or it is too small. As
the relationship between FEV1 and FVC is so strong and
almost independent of age (esp. in the middle-aged and
elderly), the authors suggest to use this relationship
directly. According to our idea, the new index (called
Figure 4 Standardized Spirometric Aberration Index (SAI)
plotted against age. Gray dots - the studied material, the bold line
- the predicted value (equal to SAI = 0), the thin line - the lower limit
of normal (equal to SAI= −1).
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culated with the following formula:
SAI ¼ FEV1m−FEV1p ð4Þ
where FEV1m is the measured patient’s FEV1 whereas
FEV1p is the FEV1 value expected for the measured
patient’s FVC, i.e. FEV1p is the FEV1 value predicted
using the Equation (1) with coefficients shown in Table 2
(for Polish population; other ethnic groups should have
own coefficients). Thus:
SAI ¼ FEV1m−A FVC−C ð5Þ
Note that SAI - like FEV1/FVC – can show whether
patient’s FEV1 is too small in relation to the one pre-
dicted by his/her FVC. Additionally, it might suggest the
obstruction severity.
The mean value of SAI for all healthy subjects is equal
to zero from the definition of the linear regression. Dis-
persion of SAI in healthy subjects depends weakly on
the FVC value, and thus on age, since FVC depends on
age. Dispersion fall with age seems to be comprehensible
because relative rather than absolute changes of FEV1
have physiological meaning. For example, FEV1 decrease
by 1 l from 2 l to 1 l is much more significant for
patient’s state in comparison with the same absolute de-
crease but from 4 to 3 l.
As SAI dispersion depends weakly on FVC (or age), its
LLN (SAILLN) has to depend on FVC (or age), too. To
make diagnosing simpler and easier, the authors propose
to use the standardized SAI, i.e.:
SAIs ¼ −SAI=SAILLN ð6Þ
Such standardization is analogous to standardizing in
mathematical statistics (to random variable
normalization), however with LLN instead of the standard
deviation. Thus, the mean value of SAIs is equal to zero,
like in the case of SAI, while LLN of SAIs is equal to −1.
Note that LLN of SAI can be related to either age or
FVC, i.e. LLN can be determined either for subjects of a
particular age (like the present LLN of FEV1/FVC, FEV1,
and the other spirometric indices) or for subjects with a
particular value of FVC. Future clinical studies should show
which LLN is better from the clinical point of view.
Figure 4 presents dependence of SAIs on age for the
analyzed population, when SAILLN (related to age) used
in standardization (formula 6) were as follows:
SAILLN ¼ 0:0056⋅age−0:800 for males
SAILLN ¼ 0:0038⋅age−0:553 for females:
It should be stressed, that if severe obstruction decreases
FVC, the SAI value may suggest a lower severity. However,
the same problem concerns FEV1/FVC. Thus SAI is notworse than FEV1/FVC. Further analysis of data for patients
suffering from obstructive lung diseases of various severity
should show whether SAI is better than FEV1/FVC.
Conclusions
Although age-dependence of both FEV1 and FVC is
related to physiological ageing, FEV1/FVC dependence on
age in healthy individuals is of mathematical rather than
biological nature, i.e. in healthy persons FVC determines
FEV1 without respect to other factors (including age) and
FEV1/FVC is a mathematically wrong description of this
relation between FEV1 and FVC. The difference between
patient’s FEV1 and FEV1 predicted for patient’s FVC may
be a more accurate and natural measure of correspond-
ence between FEV1 and FVC.
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